Companies dedicated to fetal macrosomia address the challenges associated with large fetal size during pregnancy. They focus on research, development, and solutions aimed at managing and preventing complications related to excessive fetal growth, ensuring the well-being of both mother and baby.
Philips acquires iSchemaView for $225 million deal strengthens Philips' imaging portfolio, adding iSchemaView's AI-powered fetal growth assessment tools to their arsenal for earlier and more accurate detection of potential macrosomia cases.
Viz.ai and GE Healthcare are developing AI algorithms that analyze ultrasound images, potentially identifying babies at risk of macrosomia with greater accuracy.
Volpara Health and FetalMetrics are creating devices and software that utilize maternal measurements and ultrasound data to provide more precise fetal weight estimates, aiding in managing macrosomia risks.
List of Fetal Macrosomia Key Companies in the Market
The Fetal Macrosomia Market is expected to reach USD 4,826.2 Million by 2030 at 7.6% CAGR during the forecast period 2022-2030.
Â
Sources: National Center for Biotechnology Information, SA Health, U.S. National Library of Medicine, Directorate of Industries, Annual report, White paper, Company Presentation
Key players for global fetal macrosomia market: Â Â Â Â
Some of the key players in this market are: Carestream Health (US), Esaote SpA (Italy), Fonar Corporation (US), Fujifilm Holdings Corporation (Japan), GE Healthcare (UK), Hitachi Medical Corporation (Japan), Hologic, Inc. (US), Philips Healthcare (Netherlands), Samsung Medison Co. Ltd (Republic of Korea), Shimadzu Corporation (Japan), Siemens Healthcare (Germany), Toshiba Corporation (Japan),) and others.
Fetal Macrosomia Market Segments:
Global Fetal macrosomia market has been segmented on the basis of diagnosis which comprise of ultrasound, antenatal testing, and others. Ultrasound is further sub-segmented into standard ultrasound, transvaginal scan, fetal echocardiography, 3-d ultrasound, dynamic 3-d ultrasound, and others. Antenatal testing is further sub-segmented into blood and urine tests, amniocentesis, chorionic villus sampling, and others.
On the basis of treatments, the market has been segmented into medical care, surgical care, and others. Surgical Care is sub-segmented into cesarean delivery, and others.
On the basis of end user, it is segmented into hospital and clinics, medical research centers, academic institutes, and others.
Research Methodology:
 Sources: National Center for Biotechnology Information, SA Health, U.S. National Library of Medicine, Directorate of Industries, Annual report, White paper, Company Presentation
 Regional Analysis of Fetal Macrosomia Market: Â
Considering the global scenario of the fetal macrosomia market, Americas is the largest market for fetal macrosomia. The Americas mainly include North America and South America, out of which North America is holding majority of market share of this region. US is the top revenue generating market in North America. Various factors are leading the market growth such as availability of advanced diagnostic and treatment options, funding for research and clinical trials etc. South America fetal macrosomia market is also growing significantly and mainly includes Brazil, Argentina and Chile.  Europe is another important market for fetal macrosomia. Increasing incidence of fetal macrosomia is a major driving force of this market. Europe is mainly divided into Eastern Europe and Western Europe. West European countries like Germany, UK and France are dominating this market while East European region is also growing significantly. Asia Pacific region is showing the fastest growth rate in global fetal macrosomia market due to some major factors such as developing healthcare facilities, increasing awareness, and changing healthcare facilities. China is holding major market share while India fetal market is expected to have fastest growth in this region. Government initiatives to increase awareness plays important role in the growth of this market. Middle East & Africa is expected to have a limited growth due to lack of knowledge of disorders, traditional healthcare practices etc. Middle East region is dominating this market due to some major factors like developed healthcare facilities and government support to improve public health.
The report for Global Fetal Macrosomia Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regionsÂ
Intended Audience:
Â
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)